CN110538135A - Agilawood essential oil essence and preparation method thereof - Google Patents
Agilawood essential oil essence and preparation method thereof Download PDFInfo
- Publication number
- CN110538135A CN110538135A CN201910964664.2A CN201910964664A CN110538135A CN 110538135 A CN110538135 A CN 110538135A CN 201910964664 A CN201910964664 A CN 201910964664A CN 110538135 A CN110538135 A CN 110538135A
- Authority
- CN
- China
- Prior art keywords
- fermentation product
- extract
- essential oil
- yeast
- agilawood essential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of daily chemical industry, and provides agilawood essential oil essence and a preparation method thereof, which are used for improving the effect of improving skin darkness of an essence product. The agilawood essential oil essence provided by the invention comprises 1-10% of butanediol, 0.01-1% of sodium hyaluronate, 0.01-1% of xanthan gum, 0.01-0.5% of allantoin, 0.5-8% of hydroxyethyl urea, 0.5-8% of betaine, 1-8% of glycerol, 0.5-5% of an antibacterial agent, 0.2-2% of trehalose, 0.3-6% of a plant extract, 0.1-2% of tranexamic acid, 0.1-2% of nicotinamide, 0.2-4% of a bacillus fermentation product, 0.1-2% of 1-methylhydantoin-2-imide, 10.1-2% of oligopeptide, 0.1-2% of a yeast fermentation product, 0.1-5% of an antioxidant, 0.5-5% of rose water, 0.1-5% of glycerol polyether-260.1, 0.01-2% of agilawood essential oil, 0.02-4% of PEG-40 hydrogenated castor oil, and the antioxidant comprises fullerene. The agilawood essential oil is compounded with a certain plant extract and a fermentation product, so that the quality of the cosmetic can be improved, and the prepared essence can effectively moisten the skin, relieve the symptoms of chloasma and improve the skin quality.
Description
Technical Field
The invention relates to the field of daily-use chemical industry, and particularly relates to agilawood essential oil essence and a preparation method thereof.
Background
Human skin is composed of three parts, namely the superficial part (epidermis), the dermis and the deep part (subcutaneous tissue).
Hyperpigmentation of pigment in a specific area of the skin, which makes the skin color of the area darker than that of the surrounding area, forms spots, and the common spot types include chloasma, freckle, inflammatory pigmentation and the like. Among them, chloasma is a pigmentation phenomenon commonly seen in middle-aged women, and is expressed as symmetrical flaky light brown or dark brown pigmentation spots on the cheek, the pathogenesis of which is not completely clear, and the current research shows that the levels of sunlight and sex hormones are main factors, and the chloasma can also be caused by skin barrier dysfunction, certain medicines, chronic diseases, genetic factors, skin microecological imbalance, heavy metal contact and the like.
how to improve the quality of cosmetics and skin by utilizing agilawood is a technical problem to be solved urgently at present.
disclosure of Invention
The invention provides agilawood essential oil essence for improving the skin tightening effect of an essence product.
In order to solve the technical problems, the technical scheme provided by the invention is as follows:
The agilawood essential oil essence comprises 1-10% of butanediol, 0.01-1% of sodium hyaluronate, 0.01-1% of xanthan gum, 0.01-0.5% of allantoin, 0.5-8% of hydroxyethyl urea, 0.5-8% of betaine, 1-8% of glycerol, 0.5-5% of an antibacterial agent, 0.2-2% of trehalose, 0.3-6% of a plant extract, 0.1-2% of tranexamic acid, 0.1-2% of nicotinamide, 0.2-4% of a bacillus fermentation product, 0.1-2% of 1-methylhydantoin-2-imide, 10.1-2% of oligopeptide-10.1-2%, 0.1-2% of a yeast fermentation product, 0.1-5% of an antioxidant, 0.5-5% of rose water, 260.1-5% of glycerol polyether, 0.01-2% of agilawood essential oil, 0.02-4% of PEG-40 hydrogenated castor oil, and the balance.
The agilawood essential oil is compounded with other substances, so that the quality of the essence can be effectively improved.
The agilawood essential oil is compounded with a certain plant extract, so that the quality of the cosmetic can be improved, and the prepared essence can effectively moisten the skin and improve the skin quality.
Preferably, the antibacterial agent is one or more of water, propylene glycol, biogel-1, phenoxyethanol and methylparaben.
Preferably, the plant extract is 0.1-2% of Hamamelis virginiana extract, 0.1-2% of Caesalpinia crista extract and 0.1-2% of Magnolia biondii extract or/and mint leaf extract. The moisturizing effect of the essence can be effectively improved by compounding a plurality of plant extracts.
Preferably, the hamamelis virginiana extract is a mixture of butanediol and a hamamelis virginiana extract, the caesalpinia spinosa extract is a mixture of water, glycerol, caesalpinia spinosa gum, phenoxyethanol and potassium sorbate, and the hope spring flower extract is an extract of flower buds or flowers of hope spring flowers.
preferably, the bacillus fermentation product comprises 0.1-2% of a first bacillus fermentation product and 0.1-2% of a second bacillus fermentation product, the first bacillus fermentation product is a mixture of the bacillus fermentation product and dextrin, and the second bacillus fermentation product is a mixture of water, propylene glycol, the bacillus fermentation product and 1, 2-hexanediol. Preferably, a certain amount of plant extract is combined with the agilawood essential oil, so that the skin quality can be effectively improved, the skin can be nourished, and especially, the skin quality can be improved to a certain extent by mixing a plurality of extracts.
Preferably, the yeast fermentation product is one or more of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product and yeast/silicon fermentation product. Several fermentation products are added into the system, and can further generate a synergistic effect with the agilawood to improve the skin quality.
Preferably, the antioxidant is one or a mixture of more of fullerene, xanthan gum, butanediol and water.
The preparation method of the agilawood essential oil essence comprises the following steps:
S11, adding water, butanediol, sodium hyaluronate and xanthan gum into an emulsifying device, stirring at 30-40 r/min, heating to 82-85 ℃, and preserving heat for 5-15 min after all substances are completely dissolved;
S12, slowly cooling to 50 ℃, adding allantoin, hydroxyethyl urea, betaine, glycerol, an antibacterial agent, trehalose, a Hamamelis virginiana extract and a Caesalpinia spinosa extract, and uniformly stirring at 30-40 r/min;
S13, slowly cooling to 40 ℃, adding the rest raw materials, and uniformly stirring at 30-40 r/min;
S14, slowly cooling to 32 ℃, filtering and discharging.
preferably, the allantoin, hydroxyethyl urea, betaine, glycerin, antimicrobial agent, trehalose, hamamelis virginiana extract, and Caesalpinia spinosa extract are mixed with 5% water and then added into an emulsifying device.
Preferably, in the step S14, 200-mesh filter cloth is used for the filtration.
compared with the prior art, the invention has the beneficial effects that: the agilawood essential oil is compounded with a certain amount of plant extracts and bacteria fermentation products to improve the quality of cosmetics, so that the prepared essence can effectively moisten the skin, relieve the symptoms of chloasma and improve the skin quality.
Detailed Description
The following examples are further illustrative of the present invention and are not intended to be limiting thereof.
Example 1
The agilawood essential oil essence comprises 5% of butanediol, 2% of sodium hyaluronate, 2% of xanthan gum, 0.3% of allantoin, 2% of hydroxyethyl urea, 4% of betaine, 6% of glycerol, 2.5% of an antibacterial agent, 1% of trehalose, 3.9% of a plant extract, 1% of tranexamic acid, 0.8% of nicotinamide, 2.8% of a bacillus fermentation product, 1% of 1-methylhydantoin-2-imide, 10.5% of oligopeptide, 1.5% of a yeast fermentation product, 2.4% of an antioxidant, 2% of rose water, 261% of glycerol polyether, 1% of agilawood essential oil, 3% of PEG-40 hydrogenated castor oil, the antioxidant comprises fullerene, and the balance of water is 54. The antibacterial agent is a mixture of 0.5% of water, propylene glycol, biogum glycocoll-1, phenoxyethanol and methylparaben. The plant extracts comprise 1% of Hamamelis virginiana extract, 1.5% of Caesalpinia spinosa extract, 0.7% of Magnolia biondii extract and 0.7% of mint leaf extract respectively. The Hamamelis virginiana extract is a mixture of 0.8% of butanediol and 0.2% of Hamamelis virginiana extract, the Caesalpinia spinosa extract is a mixture of 0.3% of water, 0.3% of glycerol, 0.3% of Caesalpinia spinosa gum, 0.3% of phenoxyethanol and 0.3% of potassium sorbate, and the hope spring flower extract is an extract of flower buds or flowers of the hope spring flower. The bacillus fermentation product comprises 1.2% of a first bacillus fermentation product and 1.6% of a second bacillus fermentation product, wherein the first bacillus fermentation product is a mixture of 0.6% of the bacillus fermentation product and 0.6% of dextrin, and the second bacillus fermentation product is a mixture of 0.4% of water, 0.4% of propylene glycol, 0.4% of the bacillus fermentation product and 0.4% of 1, 2-hexanediol. The yeast fermentation product is a mixture of 0.3% of each of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product and yeast/silicon fermentation product. The antioxidant is a mixture of 0.6% of each of fullerene, xanthan gum, butanediol and water.
The agilawood essential oil is compounded with other substances, so that the quality of the essence can be effectively improved. The agilawood essential oil is compounded with a certain plant extract, so that the quality of the cosmetic can be improved, and the prepared essence can effectively moisten the skin and improve the skin quality. Preferably, a certain amount of plant extract is combined with the agilawood essential oil, so that the skin quality can be effectively improved, the skin can be nourished, and especially, the skin quality can be improved to a certain extent by mixing a plurality of extracts. The plant extracts are dissolved by a certain solvent and then added into a system, and can further generate a synergistic effect with the agilawood to improve the skin quality.
Example 2
Agilawood essential oil essence comprises 1% of butanediol, 0.01% of sodium hyaluronate, 0.01% of xanthan gum, 0.01% of allantoin, 0.5% of hydroxyethyl urea, 0.5% of betaine, 1% of glycerol, 0.5% of antibacterial agent, 0.2% of trehalose, 0.3% of plant extract, 0.1% of tranexamic acid, 0.1% of nicotinamide, 0.2% of bacillus fermentation product, 0.1% of 1-methylhydantoin-2-imide, 10.1% of oligopeptide, 0.1% of yeast fermentation product, 0.1% of antioxidant, 0.5% of rose water, 260.1% of glyceryl polyether, 0.01% of agilawood essential oil, 0.02% of PEG-40 hydrogenated castor oil, the antioxidant comprises fullerene, and the balance of water 94.54%. The antibacterial agent is a mixture of 0.1% of water, propylene glycol, biogum glycocoll-1, phenoxyethanol and methylparaben. The plant extracts comprise Hamamelis virginiana extract 0.1%, Caesalpinia spinosa extract 0.1%, and flos Hoveniae extract and folium Menthae extract 0.05% respectively. The Hamamelis virginiana extract is a mixture of 0.08% of butanediol and 0.02% of Hamamelis virginiana extract, the Caesalpinia spinosa extract is a mixture of 0.03% of water, 0.02% of glycerol, 0.03% of Caesalpinia spinosa gum, 0.01% of phenoxyethanol and 0.01% of potassium sorbate, and the Magnolia biondii extract is an extract of flower buds or flowers of Magnolia biondii. The bacillus fermentation product comprises 0.1% of a first bacillus fermentation product and 0.1% of a second bacillus fermentation product, wherein the first bacillus fermentation product is a mixture of 0.05% of the bacillus fermentation product and 0.05% of homodextrin, and the second bacillus fermentation product is a mixture of 0.025% of water, 0.025% of propylene glycol, 0.025% of the bacillus fermentation product and 0.025% of 1, 2-hexanediol. The yeast fermentation product is a mixture of 0.02% of each of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product and yeast/silicon fermentation product. The antioxidant is a mixture of 0.025% of each of fullerene, xanthan gum, butanediol and water.
example 3
The agilawood essential oil essence comprises 10% of butanediol, 1% of sodium hyaluronate, 1% of xanthan gum, 0.5% of allantoin, 8% of hydroxyethyl urea, 8% of betaine, 8% of glycerol, 5% of an antibacterial agent, 2% of trehalose, 6% of a plant extract, 2% of tranexamic acid, 2% of nicotinamide, 4% of a bacillus fermentation product, 2% of 1-methylhydantoin-2-imide, 12% of oligopeptide, 2% of a yeast fermentation product, 5% of an antioxidant, 5% of rose water, 5% of glycerol polyether-265, 2% of agilawood essential oil, 4% of PEG-40 hydrogenated castor oil, the antioxidant comprises fullerene and the balance of water is. The antibacterial agent is a mixture of 1% of water, propylene glycol, biogum glycocoll-1, phenoxyethanol and methylparaben. The plant extracts comprise 2% of Hamamelis virginiana extract, 2% of Caesalpinia spinosa extract, 1% of Magnolia biondii extract and 1% of mint leaf extract respectively. The Hamamelis virginiana extract is a mixture of 1.6% of butanediol and 0.4% of a Hamamelis virginiana extract, the Caesalpinia spinosa extract is a mixture of 0.5% of water, 0.3% of glycerol, 0.6% of Caesalpinia spinosa gum, 0.3% of phenoxyethanol and 0.3% of potassium sorbate, and the hope spring flower extract is an extract of flower buds or flowers of the hope spring flower. The bacillus fermentation product comprises 2% of a first bacillus fermentation product and 2% of a second bacillus fermentation product, the first bacillus fermentation product is a mixture of 1% of the bacillus fermentation product and 1% of dextrin, and the second bacillus fermentation product is a mixture of 0.5% of water, 0.5% of propylene glycol, 0.5% of the bacillus fermentation product and 0.5% of 1, 2-hexanediol. The yeast fermentation product is a mixture of 0.4% of each of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product and yeast/silicon fermentation product. The antioxidant is a mixture of 1% of fullerene, xanthan gum, butanediol and water.
Example 4
The preparation method of the agilawood essential oil essence comprises the following steps:
s11, adding 5% of butanediol, 2% of sodium hyaluronate and 2% of xanthan gum into an emulsifying device, stirring at 35r/min, heating to 82-85 ℃, and preserving heat for 10min after all substances are completely dissolved;
S12, slowly cooling to 50 ℃, adding 49.3% of water, 0.3% of allantoin, 2% of hydroxyethyl urea, 4% of betaine, 6% of glycerol, 2.5% of an antibacterial agent, 1% of trehalose, 1% of a Hamamelis virginiana extract, 1.5% of a Caesalpinia spinosa extract and uniformly stirring at 35 r/min; the Hamamelis virginiana extract is a mixture of 0.8% of butanediol and 0.2% of Hamamelis virginiana extract, and the Caesalpinia spinosa extract is a mixture of 0.3% of water, 0.3% of glycerol, 0.3% of Caesalpinia spinosa gum, 0.3% of phenoxyethanol and 0.3% of potassium sorbate; the antibacterial agent is a mixture of 0.5% of water, propylene glycol, biogum glycocoll-1, phenoxyethanol and methylparaben;
S13, slowly cooling to 40 ℃, adding 5% of water, 1% of tranexamic acid, 0.8% of nicotinamide, 1.2% of a first bacillus fermentation product, 1% of 1-methylhydantoin-2-imide, 0.7% of each of a gomphostema longituba extract and a mint leaf extract, 1.6% of a second bacillus fermentation product, a yeast/zinc fermentation product, a yeast/calcium fermentation product, a yeast/magnesium fermentation product, a yeast/iron fermentation product and a yeast/silicon fermentation product, 0.3% of each of a mixture, oligopeptide-10.5%, 2.4% of an antioxidant, 2% of rose water, 261% of glyceryl polyether, 1% of agilawood essential oil, 3% of PEG-40 hydrogenated castor oil and 35r/min, and uniformly stirring; the antioxidant is a mixture of 0.6% of fullerene, xanthan gum, butanediol and water respectively; the first bacillus fermentation product is a mixture of 0.6% of bacillus fermentation product and 0.6% of dextrin, and the second bacillus fermentation product is a mixture of 0.4% of water, 0.4% of propylene glycol, 0.4% of bacillus fermentation product and 0.4% of 1, 2-hexanediol;
S14, slowly cooling to 32 ℃, filtering and discharging.
Example 5
The preparation method of the agilawood essential oil essence comprises the following steps:
S11, adding 1% of butanediol, 0.01% of sodium hyaluronate and 0.01% of xanthan gum into an emulsifying device, stirring at 35r/min, heating to 82-85 ℃, and preserving heat for 10min after all substances are completely dissolved;
s12, slowly cooling to 50 ℃, adding 89.54% of water, 0.01% of allantoin, 0.5% of hydroxyethyl urea, 0.5% of betaine, 1% of glycerol, 0.5% of an antibacterial agent, 0.2% of trehalose, 0.1% of a witch hazel extract, 0.1% of a caesalpinia spinosa extract and uniformly stirring at 35 r/min; the Hamamelis virginiana extract is a mixture of 0.08% of butanediol and 0.02% of Hamamelis virginiana extract, and the Caesalpinia spinosa extract is a mixture of 0.03% of water, 0.02% of glycerol, 0.03% of Caesalpinia spinosa gum, 0.01% of phenoxyethanol and 0.01% of potassium sorbate; the antibacterial agent is a mixture of 0.1% of water, propylene glycol, biogel-1, phenoxyethanol and methylparaben
S13, slowly cooling to 40 ℃, adding 5% of water, 0.1% of tranexamic acid, 0.1% of nicotinamide, 0.1% of a first bacillus fermentation product, 0.1% of 1-methylhydantoin-2-imide, 0.05% of each of a gomphostema longituba extract and a mint leaf extract, 0.1% of a second bacillus fermentation product, 0.1% of a yeast fermentation product which is a yeast/zinc fermentation product, a yeast/calcium fermentation product, a yeast/magnesium fermentation product, a yeast/iron fermentation product and a yeast/silicon fermentation product which are 0.02% of each mixture, 10.1% of oligopeptide, 0.1% of an antioxidant, 0.5% of rose water, 260.1% of glycerol polyether, 0.01% of agilawood, 0.02% of PEG-40 hydrogenated castor oil and 35r/min, and uniformly stirring; the first bacillus fermentation product is a mixture of 0.05 percent of bacillus fermentation product and 0.05 percent of dextrin, and the second bacillus fermentation product is a mixture of 0.025 percent of water, 0.025 percent of propylene glycol, 0.025 percent of bacillus fermentation product and 0.025 percent of 1, 2-hexanediol; the antioxidant is a mixture of 0.6% of fullerene, xanthan gum, butanediol and water respectively;
S14, slowly cooling to 32 ℃, filtering and discharging.
example 6
The preparation method of the agilawood essential oil essence comprises the following steps:
S11, adding 10% of butanediol, 1% of sodium hyaluronate and 1% of xanthan gum into an emulsifying device, stirring at 35r/min, heating to 82-85 ℃, and preserving heat for 10min after all substances are completely dissolved;
S12, slowly cooling to 50 ℃, adding 10.5% of water, 0.5% of allantoin, 8% of hydroxyethyl urea, 8% of betaine, 8% of glycerol, 5% of an antibacterial agent, 2% of trehalose, 2% of a hamamelis virginiana extract, 2% of a caesalpinia spinosa extract and uniformly stirring at 35 r/min; the Hamamelis virginiana extract is a mixture of 1.6% of butanediol and 0.4% of Hamamelis virginiana extract, and the Caesalpinia spinosa extract is a mixture of 0.5% of water, 0.3% of glycerol, 0.6% of Caesalpinia spinosa gum, 0.3% of phenoxyethanol and 0.3% of potassium sorbate; the antibacterial agent is a mixture of 1% of water, propylene glycol, biogum glycocoll-1, phenoxyethanol and methylparaben;
S13, slowly cooling to 40 ℃, adding 5% of water, 2% of tranexamic acid, 2% of nicotinamide, 2% of a bacillus fermentation product, 2% of 1-methylhydantoin-2-imide, 1% of each of a magnolia biondii flower extract and a mint leaf extract, 2% of a second bacillus fermentation product, 0.4% of each of a yeast/zinc fermentation product, a yeast/calcium fermentation product, a yeast/magnesium fermentation product, a yeast/iron fermentation product and a yeast/silicon fermentation product, oligopeptide-12%, 5% of an antioxidant, 5% of rose water, 5% of glycerol polyether-265%, 2% of agilawood essential oil, 4% of PEG-40 hydrogenated castor oil and 35r/min, and uniformly stirring; the antioxidant is a mixture of 1% of fullerene, xanthan gum, butanediol and water; the first bacillus fermentation product is a mixture of 1% of bacillus fermentation product and 1% of dextrin, and the second bacillus fermentation product is a mixture of 0.5% of water, 0.5% of propylene glycol, 0.5% of bacillus fermentation product and 0.5% of 1, 2-hexanediol;
S14, slowly cooling to 32 ℃, filtering and discharging.
Example 7
example 7 is the same as example 4 except that the first and second bacillus fermentation products are not added in the S13 step, and the rest is the same as example 4.
example 8
Example 8 is the same as example 4 except that the yeast fermentation product was not added in the step of S13, and the rest is the same as example 4.
Example 9
Example 9 differs from example 4 in that hamamelis virginiana extract and caesalpinia spinosa extract are not added in the step S12; the rest is the same as example 4.
Example 10
Example 10 is different from example 4 in that the yeast fermentation product in the S13 step is 0.375% each of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, and yeast/iron fermentation product; the rest is the same as example 4.
Example 11
Example 11 is different from example 4 in that the yeast fermentation product in the S13 step is 0.375% each of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, and yeast/silicon fermentation product; the rest is the same as example 4.
Example 12
example 12 differs from example 4 in that the yeast fermentation product in the S13 step is 0.375% each of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/iron fermentation product, and yeast/silicon fermentation product; the rest is the same as example 4.
Example 13
Example 13 differs from example 4 in that the yeast fermentation product in the S13 step is 0.375% each of yeast/zinc fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product, and yeast/silicon fermentation product; the rest is the same as example 4.
Example 14
example 13 differs from example 4 in that the yeast fermentation product in the step S13 is 0.375% each of yeast/calcium fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product, and yeast/silicon fermentation product; the rest is the same as example 4.
comparative example
the comparative example is the same as example 4 except that the essence does not contain agilawood essential oil and is replaced by water, and the rest is the same as example 4.
Examples of the experiments
the hair on the left side of the back of a mouse is removed, the mouse is depilated by a sodium sulfide solution, and the skin of the mouse in a 1.5cm square is exposed and depilated once a week. The muscle of hind limb was injected daily with progesterone solution 2ml/kg body mass for 6 days per week. The skin is irradiated with ultraviolet rays with a wavelength of 320nm for 30min every day, and the distance between the light source and the skin of the mouse is about 20-30 cm. The change of the skin of the mouse is observed every day, the molding time is 28 days, and 110 mice with chloasma symptoms are screened.
The mice were divided into 11 groups of 10 mice each, and the skin area was coated daily with serum, covered with a paper sheet, and then fixed appropriately with medical tape. After 28 days of application, each group of mice was sacrificed and the number of melanocytes and the average optical density of melanocytes were measured on the skin of the exposed portion.
Another 10 mice showing chloasma symptoms were used as blanks.
TABLE 1 skin melanocyte State
as can be seen from table 1, examples 4 to 6 all have a certain effect of relieving chloasma, and compared with the comparative example, the number of melanocytes and the average optical density value thereof are both significantly smaller than those of the comparative example and the blank, and the optical density of the melanocytes and the melanocytes is significantly lower than those of the other examples and comparative examples, which indicates that the mixed use of agilawood, plant extract and fermentation product produces a certain synergistic effect, so that the quality of skin is improved together, and the amount of melanin is reduced.
Example 1 is a better embodiment, the number of people is improved most, and the improvement degree of chloasma is higher; the components in the embodiment 2 are less in dosage, and the effect of improving the chloasma is still remarkable compared with the effect of a comparative example, which shows that the effect of the fermentation product containing the agilawood essential oil and the plant extract on the aspect of improving the chloasma is extremely important; the comparative example adopts no agilawood essential oil, so that the user has poor response and the improvement effect on chloasma is not obvious; it is shown that only the combination of the agilawood essential oil and the plant extract can produce good effect of improving the skin.
The embodiments 7 to 9 respectively only contain two of the plant extract, the yeast fermentation product and the bacillus, and have a considerable difference with the embodiment 4, and the effect of improving chloasma is poor, which indicates that the combination of the plant extract, the yeast fermentation product, the bacillus fermentation product and the agilawood essential oil has an important effect of improving the quality of skin. The yeast fermentation products in the examples 10 to 14 are a mixture of 4 of 5 fermentation products, and the effect of improving chloasma is stronger than that of the examples 7 to 9 but still weaker than that of the examples 1 to 3, which shows that the combination of the 5 yeast fermentation products can bring about a remarkable effect of improving chloasma.
The above detailed description is specific to possible embodiments of the present invention, and the above embodiments are not intended to limit the scope of the present invention, and all equivalent implementations or modifications that do not depart from the scope of the present invention should be included in the present claims.
Claims (10)
1. the agilawood essential oil essence is characterized by comprising 1-10% of butanediol, 0.01-1% of sodium hyaluronate, 0.01-1% of xanthan gum, 0.01-0.5% of allantoin, 0.5-8% of hydroxyethyl urea, 0.5-8% of betaine, 1-8% of glycerol, 0.5-5% of an antibacterial agent, 0.2-2% of trehalose, 0.3-6% of a plant extract, 0.1-2% of tranexamic acid, 0.1-2% of nicotinamide, 0.2-4% of a bacillus fermentation product, 0.1-2% of 1-methylhydantoin-2-imide, 10.1-2% of oligopeptide, 0.1-2% of a yeast fermentation product, 0.1-5% of an antioxidant, 0.5-5% of rose water, 0.1-5% of glycerol polyether-260.1, 0.01-2% of agilawood essential oil, 0.02-4% of PEG-40 hydrogenated castor oil, and the antioxidant comprises fullerene and.
2. The agilawood essential oil essence liquid according to claim 1, wherein the antibacterial agent is one or more of water, propylene glycol, biogel-1, phenoxyethanol and methylparaben.
3. The agilawood essential oil essence as claimed in claim 1, wherein the plant extract is hamamelis virginiana extract 0.1-2%, Caesalpinia crista extract 0.1-2%, and Magnolia biondii extract or/and mint leaf extract 0.1-2%.
4. the agilawood essential oil essence liquid of claim 3, wherein the hamamelis virginiana extract is a mixture of butylene glycol and a hamamelis virginiana extract, the caesalpinia spinosa extract is a mixture of water, glycerin, caesalpinia spinosa gum, phenoxyethanol and potassium sorbate, and the hopechun flower extract is an extract of flower buds or flowers of hopechun flower.
5. The agilawood essential oil essence liquid according to claim 1, wherein the bacillus fermentation product comprises 0.1-2% of a first bacillus fermentation product and 0.1-2% of a second bacillus fermentation product, the first bacillus fermentation product is a mixture of the bacillus fermentation product and dextrin, and the second bacillus fermentation product is a mixture of water, propylene glycol, the bacillus fermentation product and 1, 2-hexanediol.
6. The agilawood essential oil essence liquid according to claim 1, wherein the yeast fermentation product is one or more of yeast/zinc fermentation product, yeast/calcium fermentation product, yeast/magnesium fermentation product, yeast/iron fermentation product and yeast/silicon fermentation product.
7. The agilawood essential oil essence as claimed in claim 1, wherein the antioxidant is one or a mixture of fullerene, xanthan gum, butanediol and water.
8. The preparation method of the agilawood essential oil essence is characterized by comprising the following steps:
S11, adding water, butanediol, sodium hyaluronate and xanthan gum into an emulsifying device, stirring at 30-40 r/min, heating to 82-85 ℃, and preserving heat for 5-15 min after all substances are completely dissolved;
S12, slowly cooling to 45-55 ℃, adding allantoin, hydroxyethyl urea, betaine, glycerol, an antibacterial agent, trehalose, a Hamamelis virginiana extract and a Caesalpinia spinosa extract, and uniformly stirring at a speed of 30-40 r/min;
S13, slowly cooling to 35-45 ℃, adding the rest raw materials, and uniformly stirring at 30-40 r/min;
s14, slowly cooling to 30-35 ℃, filtering and discharging.
9. The method of claim 8, wherein the allantoin, hydroxyethyl urea, betaine, glycerin, an antibacterial agent, trehalose, Hamamelis virginiana extract, and Caesalpinia spinosa extract are mixed with 5% water and added to an emulsifying device.
10. The preparation method of the agilawood essential oil essence liquid according to claim 8, wherein in the step S14, 200-mesh filter cloth is adopted for filtering.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910964664.2A CN110538135A (en) | 2019-10-11 | 2019-10-11 | Agilawood essential oil essence and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910964664.2A CN110538135A (en) | 2019-10-11 | 2019-10-11 | Agilawood essential oil essence and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110538135A true CN110538135A (en) | 2019-12-06 |
Family
ID=68715694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910964664.2A Pending CN110538135A (en) | 2019-10-11 | 2019-10-11 | Agilawood essential oil essence and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110538135A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110897987A (en) * | 2019-12-16 | 2020-03-24 | 广州熙然化妆品有限公司 | Composition for resisting wrinkles and tightening skin and application of composition in cosmetics |
| CN113332203A (en) * | 2021-06-30 | 2021-09-03 | 海南林鹏茶业有限公司 | Agilawood skin care product and preparation method thereof |
| CN113616534A (en) * | 2021-08-25 | 2021-11-09 | 上海美浮特生物科技有限公司 | Composition for inhibiting PAR-2 from activating keratinocytes and application of composition in facial mask |
| CN115581642A (en) * | 2022-09-08 | 2023-01-10 | 旸森生态科技有限公司 | Body-perfuming lotion with antibacterial effect and preparation method and application thereof |
| CN115969766A (en) * | 2022-12-22 | 2023-04-18 | 上海萧雅生物科技股份有限公司 | Yeast composition and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825351A (en) * | 2015-04-24 | 2015-08-12 | 东莞波顿香料有限公司 | Eaglewood whitening facial cleanser and preparation method thereof |
| CN106176411A (en) * | 2016-08-22 | 2016-12-07 | 广州市香事文化传播有限公司 | A kind of agilawood essential oil and preparation method thereof |
| CN106551849A (en) * | 2016-11-28 | 2017-04-05 | 石桐瑄 | A kind of Lignum Aquilariae Resinatum facial film and preparation technology |
| CN107164121A (en) * | 2017-05-02 | 2017-09-15 | 东莞市国正沉香生物科技有限公司 | A kind of agilawood essential oil soap with beauty functions of calming the nerves |
| CN108478519A (en) * | 2018-04-23 | 2018-09-04 | 广州雷诺生物科技有限公司 | A kind of fossil water light stoste containing fullerene |
-
2019
- 2019-10-11 CN CN201910964664.2A patent/CN110538135A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825351A (en) * | 2015-04-24 | 2015-08-12 | 东莞波顿香料有限公司 | Eaglewood whitening facial cleanser and preparation method thereof |
| CN106176411A (en) * | 2016-08-22 | 2016-12-07 | 广州市香事文化传播有限公司 | A kind of agilawood essential oil and preparation method thereof |
| CN106551849A (en) * | 2016-11-28 | 2017-04-05 | 石桐瑄 | A kind of Lignum Aquilariae Resinatum facial film and preparation technology |
| CN107164121A (en) * | 2017-05-02 | 2017-09-15 | 东莞市国正沉香生物科技有限公司 | A kind of agilawood essential oil soap with beauty functions of calming the nerves |
| CN108478519A (en) * | 2018-04-23 | 2018-09-04 | 广州雷诺生物科技有限公司 | A kind of fossil water light stoste containing fullerene |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110897987A (en) * | 2019-12-16 | 2020-03-24 | 广州熙然化妆品有限公司 | Composition for resisting wrinkles and tightening skin and application of composition in cosmetics |
| CN113332203A (en) * | 2021-06-30 | 2021-09-03 | 海南林鹏茶业有限公司 | Agilawood skin care product and preparation method thereof |
| CN113616534A (en) * | 2021-08-25 | 2021-11-09 | 上海美浮特生物科技有限公司 | Composition for inhibiting PAR-2 from activating keratinocytes and application of composition in facial mask |
| CN113616534B (en) * | 2021-08-25 | 2023-09-15 | 上海美浮特生物科技有限公司 | PAR-2-activating-inhibiting keratinocyte composition and application thereof in mask |
| CN115581642A (en) * | 2022-09-08 | 2023-01-10 | 旸森生态科技有限公司 | Body-perfuming lotion with antibacterial effect and preparation method and application thereof |
| CN115581642B (en) * | 2022-09-08 | 2023-12-22 | 旸森生态科技有限公司 | Body lotion with antibacterial effect and preparation method and application thereof |
| CN115969766A (en) * | 2022-12-22 | 2023-04-18 | 上海萧雅生物科技股份有限公司 | Yeast composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110538135A (en) | Agilawood essential oil essence and preparation method thereof | |
| CN107334726B (en) | Acne-removing composition and preparation method and application thereof | |
| CN105496938B (en) | α-bisabolol shin moisturizer | |
| KR101724147B1 (en) | Cosmetic composition having anti-itching effect containing crude drug extracts | |
| KR20200073313A (en) | Cosmetic composition containing sarcodon aspratus and magnolia liliflora buda fermented extract using Yusung hot spring water | |
| KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
| KR20080026800A (en) | Cosmetic composition | |
| US20070031367A1 (en) | Composition and method for neck skin firming | |
| CN108464961B (en) | Natural plant shampoo and preparation method thereof | |
| CN110638668A (en) | Agilawood essential oil face cream and preparation method thereof | |
| KR20070065926A (en) | Composition comprising green tea extract and brassica olecea var. botrytis extract having anti-biotic, deodorante and the use thereof | |
| KR20150106070A (en) | Cleaning composition containing extract of momordica charantia for improvement skin condition | |
| KR20080030773A (en) | Cosmetic composition for anti-wrinkle | |
| RU2295951C1 (en) | Composition for face and eyelids skin care | |
| KR101299024B1 (en) | Cosmetics composition for skin lightening color, antioxidantsand and method for preparing the same | |
| KR20150112103A (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
| CN103550511A (en) | Plant composition capable of delaying skin aging, and preparation method thereof | |
| KR20130083636A (en) | Cosmetic composition with the fermented mixture of fruits and dark vinegar | |
| KR101736478B1 (en) | Method for manufacturing lotions with effective in treating acne | |
| KR101876744B1 (en) | A step 3 method for improving skin condition using cosmetic composition comprising a ginseng extract | |
| KR20090087223A (en) | Cosmetic composition for pore-minimizing containing limonia acidissima extract | |
| CN114469817A (en) | Pore-refining composition and preparation method and application thereof | |
| KR102059620B1 (en) | Cosmetic composition for allevation of acne with the extract of Lycopus lucidus or its fraction | |
| KR20130088226A (en) | Skin external composition comprising linum usitatissimum l. seed extract | |
| KR20100122967A (en) | Cosmetic compositions used for antiaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191206 |
|
| RJ01 | Rejection of invention patent application after publication |